These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Allosteric modulators enhance agonist efficacy by increasing the residence time of a GPCR in the active state. Cao AM; Quast RB; Fatemi F; Rondard P; Pin JP; Margeat E Nat Commun; 2021 Sep; 12(1):5426. PubMed ID: 34521824 [TBL] [Abstract][Full Text] [Related]
7. Metabotropic glutamate receptors as therapeutic targets in Parkinson's disease: An update from the last 5 years of research. Litim N; Morissette M; Di Paolo T Neuropharmacology; 2017 Mar; 115():166-179. PubMed ID: 27055772 [TBL] [Abstract][Full Text] [Related]
8. Allosteric nanobodies uncover a role of hippocampal mGlu2 receptor homodimers in contextual fear consolidation. Scholler P; Nevoltris D; de Bundel D; Bossi S; Moreno-Delgado D; Rovira X; Møller TC; El Moustaine D; Mathieu M; Blanc E; McLean H; Dupuis E; Mathis G; Trinquet E; Daniel H; Valjent E; Baty D; Chames P; Rondard P; Pin JP Nat Commun; 2017 Dec; 8(1):1967. PubMed ID: 29213077 [TBL] [Abstract][Full Text] [Related]
9. A novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype selective ligands with therapeutic potential. Goudet C; Vilar B; Courtiol T; Deltheil T; Bessiron T; Brabet I; Oueslati N; Rigault D; Bertrand HO; McLean H; Daniel H; Amalric M; Acher F; Pin JP FASEB J; 2012 Apr; 26(4):1682-93. PubMed ID: 22223752 [TBL] [Abstract][Full Text] [Related]
10. Molecular Switches of Allosteric Modulation of the Metabotropic Glutamate 2 Receptor. Pérez-Benito L; Doornbos MLJ; Cordomí A; Peeters L; Lavreysen H; Pardo L; Tresadern G Structure; 2017 Jul; 25(7):1153-1162.e4. PubMed ID: 28648611 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and pharmacological evaluation of bivalent tethered ligands to target the mGlu Fulton MG; Loch MT; Rodriguez AL; Lin X; Javitch JA; Conn PJ; Niswender CM; Lindsley CW Bioorg Med Chem Lett; 2020 Jul; 30(13):127212. PubMed ID: 32371100 [TBL] [Abstract][Full Text] [Related]
12. Selective Negative Allosteric Modulation Of Metabotropic Glutamate Receptors – A Structural Perspective of Ligands and Mutants. Harpsøe K; Isberg V; Tehan BG; Weiss D; Arsova A; Marshall FH; Bräuner-Osborne H; Gloriam DE Sci Rep; 2015 Sep; 5():13869. PubMed ID: 26359761 [TBL] [Abstract][Full Text] [Related]
13. Nanobody-based sensors reveal a high proportion of mGlu heterodimers in the brain. Meng J; Xu C; Lafon PA; Roux S; Mathieu M; Zhou R; Scholler P; Blanc E; Becker JAJ; Le Merrer J; González-Maeso J; Chames P; Liu J; Pin JP; Rondard P Nat Chem Biol; 2022 Aug; 18(8):894-903. PubMed ID: 35681029 [TBL] [Abstract][Full Text] [Related]
14. Allosteric modulation of metabotropic glutamate receptors by chloride ions. Tora AS; Rovira X; Dione I; Bertrand HO; Brabet I; De Koninck Y; Doyon N; Pin JP; Acher F; Goudet C FASEB J; 2015 Oct; 29(10):4174-88. PubMed ID: 26116702 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2. Lundström L; Bissantz C; Beck J; Dellenbach M; Woltering TJ; Wichmann J; Gatti S Neuropharmacology; 2016 Dec; 111():253-265. PubMed ID: 27590915 [TBL] [Abstract][Full Text] [Related]
16. Functional impact of allosteric agonist activity of selective positive allosteric modulators of metabotropic glutamate receptor subtype 5 in regulating central nervous system function. Noetzel MJ; Rook JM; Vinson PN; Cho HP; Days E; Zhou Y; Rodriguez AL; Lavreysen H; Stauffer SR; Niswender CM; Xiang Z; Daniels JS; Jones CK; Lindsley CW; Weaver CD; Conn PJ Mol Pharmacol; 2012 Feb; 81(2):120-33. PubMed ID: 22021324 [TBL] [Abstract][Full Text] [Related]
17. Structures of human mGlu2 and mGlu7 homo- and heterodimers. Du J; Wang D; Fan H; Xu C; Tai L; Lin S; Han S; Tan Q; Wang X; Xu T; Zhang H; Chu X; Yi C; Liu P; Wang X; Zhou Y; Pin JP; Rondard P; Liu H; Liu J; Sun F; Wu B; Zhao Q Nature; 2021 Jun; 594(7864):589-593. PubMed ID: 34135509 [TBL] [Abstract][Full Text] [Related]
18. A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis. Benneyworth MA; Xiang Z; Smith RL; Garcia EE; Conn PJ; Sanders-Bush E Mol Pharmacol; 2007 Aug; 72(2):477-84. PubMed ID: 17526600 [TBL] [Abstract][Full Text] [Related]
19. Chloride is an Agonist of Group II and III Metabotropic Glutamate Receptors. DiRaddo JO; Miller EJ; Bowman-Dalley C; Wroblewska B; Javidnia M; Grajkowska E; Wolfe BB; Liotta DC; Wroblewski JT Mol Pharmacol; 2015 Sep; 88(3):450-9. PubMed ID: 26089372 [TBL] [Abstract][Full Text] [Related]
20. Structural determinants of allosteric antagonism at metabotropic glutamate receptor 2: mechanistic studies with new potent negative allosteric modulators. Lundström L; Bissantz C; Beck J; Wettstein JG; Woltering TJ; Wichmann J; Gatti S Br J Pharmacol; 2011 Sep; 164(2b):521-37. PubMed ID: 21470207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]